A newly released Disposable EEG Electrode Market analysis report by Future Market Insights shows that global sales of the Disposable EEG Electrode Market in 2022 were held at US$ 782 million. With a CAGR of 4.3% from 2023 to 2033, the market is projected to reach a valuation of US$ 1.2 billion by 2033. Needle Electrodes are expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 4.5% from 2023 to 2033.
Attribute | Details |
---|---|
Global Disposable EEG Electrode Market (2023) | US$ 816.5 million |
Global Disposable EEG Electrode Market (2033) | US$ 1.2 billion |
Global Disposable EEG Electrode Market CAGR (2023 to 2033) | 4.3% |
USA Disposable EEG Electrode Market CAGR (2023 to 2033) | 4.2% |
Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Disposable EEG Electrode Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the value of the Disposable EEG Electrode Market increased at around 4.3% CAGR.
EEG is the recording of electrical signals with the purpose of detecting anomalies in brain electrical activity. EEG is a painless process in which electrical impulses are recorded using 16-20 electrodes affixed to the patient's scalp.
An electrode is a conductor that allows an electric current to travel safely through it. Specially qualified healthcare workers monitor and interpret the EEG meter.
Disposable EEG electrodes are intended to provide precise measurements of electrical impulses in the brain. Furthermore, as compared to reusable EEG electrodes, disposable EEG electrodes limit the chance of cross-contamination and save time. Because of improved hygiene measures, disposable EEG electrodes are favored over reused EEG electrodes in COVID-19.
The rising prevalence of neurological illnesses is one of the primary trends driving the growth of the EEG electrodes market. The rising prevalence of these neurological diseases is increasing the demand for brain monitoring equipment such as EEG electrodes, which are commonly used in the diagnosis of such illnesses. Furthermore, the growing popularity of hybrid brain-computer interface approaches is propelling the EEG electrodes market forward.
EEG also aids in the diagnosis of epilepsy and other brain illnesses such as tumors, stroke, brain tissue degeneration, infections, metabolic and hormonal problems that influence brain tissue, and some central nervous system disorders.
When opposed to reusable EEG electrodes, disposable EEG electrodes are especially intended to deliver quality recordings and avoid cross-contamination which saves time as well as money. They provide meaningful, real-time EEG data in different monitoring or mapping processes. They are also used to convert ionic current energy into electrical current in the body. EEG is also used to assess sleep problems, monitor blood flow following brain surgery, and identify brain death. In operating rooms, ambulatory units, and critical care units, EEG meters are employed.
The rising prevalence of neurological illnesses, as well as technological improvement, are two main drivers driving the market. The need for disposable EEG electrodes is increasing as a result of technical improvements, an increase in the number of HAI cases, and the global incidence of neurological illnesses.
Disposable EEG electrodes help to prevent a patient from catching bacterial and other microbial illnesses. In lieu of these factors, the EEG electrodes market is expected to witness positive growth.
Parkinson's disease and epilepsy are some of the major prevailing neurological illnesses, which are driving the disposable EEG electrode market. Apart from them, dystonia and essential tremor also drive the market growth.
High death rates and illness burdens drive strong demand for magnetic brain stimulators, which are remedies that can be used for a longer period. Moreover, increased public awareness about neurological conditions has raised disposable EEG electrode market demand as a viable treatment.
Some of the factors driving the market growth for EEG electrodes are an increase in hospital-acquired infections, a swell in the geriatric population, and an increase in hygienic practices.
In 2022, North America held the largest share of the global Disposable EEG Electrode Market. North America has the largest market for electroencephalogram meters, followed by Europe, due to technical progress, rising prevalence of brain illnesses, growth in healthcare spending, innovation in digitalized equipment, and the developed healthcare sector.
Furthermore, rising merger acquisitions among major competitors in the area, as well as an increase in the frequency of neurological illnesses, are likely to drive the expansion of the region's EEG disposable medical electrodes market.
Asia is likely to witness rapid expansion in the electroencephalogram (EEG) meter market in the forthcoming years as a result of the region's improving healthcare infrastructure and rising disposable income and increased awareness of neurological diseases.
The market in the USA is expected to reach US$ 486 billion by 2032, growing at a CAGR of 4.2% from 2023 to 2033. The market is expected to register an absolute dollar opportunity of US$ 163 million during the forecast period. The growing incidence of AIS is most likely to propel the market growth since disposable EEG electrodes can be used to identify strokes in the early stages.
The market in the United Kingdom is expected to reach a valuation of US$ 653 million by 2033, growing at a CAGR of 4.9% from 2023 to 2033. The market is projected to gross an absolute dollar opportunity of US$ 422 million during the forecast period.
In Japan, the market is expected to reach a valuation of US$ 47 million by 2033. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of US$ 18 million, growing at a CAGR of 4.8%.
The market in South Korea is projected to grow at a CAGR of 4.9% from 2023 to 2033. During this period, the market is projected to witness an absolute dollar opportunity of US$ 9.4 million and reach US$ 25 million by 2033.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The needle electrode segment commanded the largest revenue as well as a CAGR of nearly 5.4%, from 2018 to 2022. Direct cortical recordings require the use of EEG electrodes. Another factor driving the market is the rise in neurological illnesses.
The therapeutic application of EEG Electrode is expected to command the largest revenue as well as a CAGR of nearly 4.2%, during the forecast period. The key driver for the Therapeutic application is the large pool of the aged population and the constant rise in their number. Emerging economies with a large population of senior citizens and increasing disposable incomes will provide a boost to this segment throughout the forecast period.
The hospital segment commanded the largest revenue share during the forecast period. This growth is because of the rise in the number of surgical procedures worldwide, as well as neurological disorders requiring disposable EEG electrodes. The availability of technologically advanced EEG devices and long-term contracts of hospitals with suppliers, which increases the supplier's negotiating power and creates a market for after-sales service, will drive the market for this segment.
To maintain their competitiveness in the market, key players in this market are working to obtain regulatory approvals for their products. Key firms are also extensively spending on research and development.
Some of the key players operating in the market include Medtronic PLC, Ambu A/S, CONMED Corporation, BIOPAC Systems Inc., Brain Scientific, Inc., and Natus Medical Incorporated.
Some of the recent developments of key Disposable EEG Electrode providers are as follows:
Similarly, recent developments related to companies’ Disposable EEG Electrode services have been tracked by the team at Future Market Insights, which are available in the full report.
The Disposable EEG Electrode market is valued at US$ 816.5 million in 2023.
The Disposable EEG Electrode market’s CAGR from 2023 to 2033 will be 4.3%.
The Disposable EEG Electrode market is anticipated to hit US$ 1.2 billion by 2023.
Medtronic PLC, Ambu A/S and CONMED Corporation are key Disposable EEG Electrode market players.
The United States is likely to surge at a CAGR of 4.2% through 2023.
1. Executive Summary | Disposable EEG Electrode Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Needle electrodes
5.3.2. Patch electrodes
5.3.3. Cup electrodes
5.3.4. Disk electrodes
5.3.5. Other Product types
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Diagnostic
6.3.2. Therapeutic
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) Analysis By End Use, 2018 to 2022
7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End Use, 2023 to 2033
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Other end uses
7.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Application
9.2.4. By End Use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.3.4. By End Use
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Application
10.2.4. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.3.4. By End Use
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. United Kingdom
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Product Type
11.2.3. By Application
11.2.4. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End Use
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.2.3. By Application
12.2.4. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End Use
12.4. Key Takeaways
13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Product Type
13.2.3. By Application
13.2.4. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End Use
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Application
14.2.4. By End Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By End Use
14.4. Key Takeaways
15. Middle East and Africa (MEA) Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Product Type
15.2.3. By Application
15.2.4. By End Use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End Use
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Application
16.1.2.3. By End Use
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Application
16.2.2.3. By End Use
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Application
16.3.2.3. By End Use
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Application
16.4.2.3. By End Use
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Application
16.5.2.3. By End Use
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Application
16.6.2.3. By End Use
16.7. Italy
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Application
16.7.2.3. By End Use
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Application
16.8.2.3. By End Use
16.9. United Kingdom
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Application
16.9.2.3. By End Use
16.10. Spain
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Application
16.10.2.3. By End Use
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Application
16.11.2.3. By End Use
16.12. BENELUX
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Application
16.12.2.3. By End Use
16.13. China
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Application
16.13.2.3. By End Use
16.14. Japan
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Application
16.14.2.3. By End Use
16.15. South Korea
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Application
16.15.2.3. By End Use
16.16. India
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Application
16.16.2.3. By End Use
16.17. Thailand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Application
16.17.2.3. By End Use
16.18. Malaysia
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Application
16.18.2.3. By End Use
16.19. Indonesia
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Application
16.19.2.3. By End Use
16.20. Australia
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Application
16.20.2.3. By End Use
16.21. New Zealand
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Application
16.21.2.3. By End Use
16.22. GCC Countries
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Application
16.22.2.3. By End Use
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Application
17.3.4. By End Use
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Medtronic PLC
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Ambu A/S
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. CONMED Corporation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. BIOPAC Systems Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Brain Scientific, Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Natus Medical Incorporated
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports